| |
|
|
| Name: |
ACORN CAPITAL ADVISORS LLC |
| City: |
NEW YORK |
| State: |
NY |
| Zip: |
10170 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
22 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
CGON |
CG Oncology, Inc |
1 |
- |
$25.95 |
$27,722,000 |
1,131,501 |
18.49% |
-4,729,000 |
0 |
1.714 |
N/A |
|
|
URGN |
Urogen Pharma Ltd. |
2 |
- |
$13.49 |
$16,770,000 |
1,516,303 |
11.18% |
621,000 |
0 |
3.601 |
N/A |
|
|
YMAB |
Y-Mabs Therapeutics Inc |
3 |
- |
$4.70 |
$14,333,000 |
3,235,387 |
9.56% |
-8,075,000 |
373,562 |
8.086 |
N/A |
|
|
TRVI |
Trevi Therapeutics, Inc. |
4 |
- |
$0.00 |
$13,491,000 |
2,144,844 |
9% |
5,247,000 |
143,796 |
2.108 |
N/A |
|
|
CADL |
Candel Therapeutics, Inc. |
5 |
- |
$0.00 |
$12,160,000 |
2,152,252 |
8.11% |
-4,676,000 |
212,608 |
7.502 |
N/A |
|
|
PBYI |
Puma Biotechnology Inc |
6 |
- |
$3.33 |
$11,663,000 |
3,940,052 |
7.78% |
-354,000 |
0 |
9.91 |
N/A |
|
|
BCAX |
Bicara Therapeutics Inc. |
7 |
- |
$8.71 |
$8,383,000 |
643,382 |
5.59% |
-2,825,000 |
1 |
1.183 |
N/A |
|
|
TARA |
Protara Therapeutics, Inc |
8 |
- |
$2.88 |
$5,452,000 |
1,279,800 |
3.64% |
-1,305,000 |
0 |
12.177 |
N/A |
|
|
TERN |
Terns Pharmaceuticals, Inc. |
9 |
- |
$3.83 |
$5,441,000 |
1,971,264 |
3.63% |
-5,480,000 |
0 |
2.347 |
N/A |
|
|
OKUR |
OnKure Therapeutics, Inc. |
10 |
- |
$2.40 |
$5,124,000 |
1,439,674 |
3.42% |
-5,124,000 |
0 |
11.381 |
N/A |
|
|
VSTM |
Verastem, Inc. |
11 |
- |
$4.15 |
$4,700,000 |
779,498 |
3.13% |
3,921,000 |
0 |
1.732 |
Biotechnology |
|
|
CYBN |
Cybin Inc |
12 |
- |
$8.15 |
$4,663,000 |
734,394 |
3.11% |
-1,814,000 |
1 |
0.082 |
N/A |
|
|
CRDF |
Cardiff Oncology Inc |
13 |
- |
$1.22 |
$4,529,000 |
1,442,308 |
3.02% |
-1,731,000 |
0 |
4.084 |
Biotechnology |
|
|
OPTN |
OptiNose Inc |
14 |
- |
$9.60 |
$3,877,000 |
422,814 |
2.59% |
1,053,000 |
1 |
4.203 |
N/A |
|
|
AADI |
Aadi Bioscience, Inc |
15 |
- |
$1.93 |
$2,028,000 |
1,139,363 |
1.35% |
-1,591,000 |
-7,689 |
5.454 |
N/A |
|
|
XFOR |
X4 Pharmaceuticals Inc |
16 |
- |
$0.19 |
$1,755,000 |
7,310,650 |
1.17% |
-3,608,000 |
0 |
4.37 |
N/A |
|
|
MURA |
Mural Oncology Plc |
17 |
- |
$2.48 |
$1,600,000 |
1,269,715 |
1.07% |
-2,541,000 |
-16,364 |
7.608 |
N/A |
|
|
AURA |
Aura Biosciences, Inc. |
18 |
New |
$0.00 |
$1,453,000 |
590,508 |
0.97% |
1,453,000 |
590,508 |
1.2 |
N/A |
|
|
BCAB |
Bioatla, Inc. |
19 |
- |
$0.00 |
$1,411,000 |
4,032,046 |
0.94% |
-973,000 |
0 |
8.744 |
N/A |
|
|
QTTB |
Q32 Bio Inc |
20 |
- |
$1.45 |
$1,326,000 |
803,425 |
0.88% |
-1,438,000 |
0 |
1.676 |
N/A |
|
|
VYNE |
VYNE Therapeutics Inc |
21 |
- |
$0.22 |
$1,242,000 |
785,938 |
0.83% |
-289,000 |
328,968 |
1.531 |
N/A |
|
|
ACRV |
Acrivon Therapeutics, Inc. |
22 |
- |
$1.20 |
$823,000 |
405,237 |
0.55% |
-1,617,000 |
0 |
1.308 |
N/A |
|
